# Boerhavia diffusa **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/boerhavia-diffusa **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 6 / 10 **Category:** Ayurveda **Also Known As:** Boerhavia diffusa, Punarnava, Red Spiderling, Spreading Hogweed, Tar Vine, Horse Purslane, Shothagni, Raktapunarnava ## Overview Boerhavia diffusa is an Ayurvedic herb containing punarnavoside and rotenoids that modulates immune responses and [inflammatory pathway](/ingredients/condition/inflammation)s. The plant demonstrates significant anti-inflammatory activity through inhibition of inflammatory mediators and enhancement of antibody production. ## Health Benefits • [Immune system](/ingredients/condition/immune-support) modulation - Alkaloidal fractions enhanced antibody responses while reducing hypersensitivity in mice studies (preliminary evidence) • [Anti-inflammatory](/ingredients/condition/inflammation) effects - Reduced paw edema by 55.78% in rat models (preliminary evidence) • Antifibrinolytic activity - Showed benefits against IUD-induced bleeding in rhesus monkey studies through prostaglandin dehydrogenase modulation (preliminary evidence) • Anti-angiogenic properties - Punarnavine compound suppressed tumor growth by downregulating VEGF-A and MMP-2/9 in animal models (preliminary evidence) • Sepsis protection - 50% mortality reduction in E. coli-infected mice with normalized glucose and cholesterol levels (preliminary evidence) ## Mechanism of Action Boerhavia diffusa's alkaloidal fractions containing punarnavoside and rotenoids modulate [immune system](/ingredients/condition/immune-support) function by enhancing antibody responses while reducing hypersensitivity reactions. The [anti-inflammatory](/ingredients/condition/inflammation) effects occur through inhibition of inflammatory mediators and reduction of edema formation. The herb also demonstrates antifibrinolytic activity, potentially affecting blood coagulation pathways. ## Clinical Summary Preliminary animal studies show Boerhavia diffusa reduced paw edema by 55.78% in rat models, indicating significant [anti-inflammatory](/ingredients/condition/inflammation) potential. Mouse studies demonstrated that alkaloidal fractions enhanced antibody responses while simultaneously reducing hypersensitivity reactions. Additional research showed antifibrinolytic activity against certain conditions. However, human clinical trials are limited, and most evidence remains at the preclinical stage. ## Nutritional Profile Boerhavia diffusa (Punarnava) contains a range of bioactive compounds rather than significant macronutrient value as a food source. Proximate composition of dried root shows moisture ~8-10%, crude protein ~8-12%, crude fiber ~15-20%, ash ~10-12%, with limited fat content (~2-4%). Key bioactive alkaloids include punarnavine (principal alkaloid, ~0.04% in roots), boeravinones (rotenoids: boeravinone A, B, C, D, E, F, G - particularly boeravinone B at concentrations up to 0.1% in roots), and liriodendrin. Flavonoids include kaempferol-3-glucoside and quercetin derivatives (~0.2-0.5% total flavonoids in aerial parts). Phenolic acids include hypoxanthine 9-L-arabinofuranoside and ursolic acid (~0.3% in roots). Sterols include β-sitosterol and stigmasterol. Potassium content is notably high (~400-600 mg/100g dried root), contributing to its diuretic properties. Calcium (~200 mg/100g), iron (~15-25 mg/100g), and magnesium (~150 mg/100g) are present in roots. Vitamin C is present in fresh leaves (~40-60 mg/100g). Bioavailability of alkaloids is enhanced by water extraction; lipophilic boeravinones show improved absorption with lipid co-administration. Rotenoid glycosides demonstrate moderate oral bioavailability with significant first-pass [metabolism](/ingredients/condition/weight-management). ## Dosage & Preparation Animal studies used aqueous extracts at 50-200 mg/kg/day orally for [immunomodulat](/ingredients/condition/immune-support)ion and sepsis. Alkaloidal fractions were tested at 25-100 mg/kg orally in mice, while isolated punarnavine was used at 15 mg/kg/day for anti-angiogenic effects. No human dosage guidelines have been established through clinical trials. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for Boerhavia diffusa in humans is limited, with most studies conducted in animal models. The herb may interact with anticoagulant medications due to its antifibrinolytic properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use, given the herb's immune-modulating effects. ## Scientific Research No large-scale human randomized controlled trials or meta-analyses have been conducted on Boerhavia diffusa. Current evidence is limited to preclinical animal studies, including research in rhesus monkeys for antifibrinolytic effects, mice models for [immunomodulat](/ingredients/condition/immune-support)ion and sepsis (50-200 mg/kg/day), and in vitro studies examining NK cell activity and [inflammatory](/ingredients/condition/inflammation) markers. ## Historical & Cultural Context Boerhavia diffusa has been used in Ayurvedic medicine for over 3,000 years as a rasayana (rejuvenator) for antiaging, disease prevention, and life strengthening. The Sanskrit name 'punarnava' means 'renewal,' and it has traditionally been prescribed for edema, liver disorders, and as a diuretic across Indian, African, and other traditional medicine systems. ## Synergistic Combinations Ashwagandha, Triphala, Turmeric, Guduchi, Licorice root ## Frequently Asked Questions ### What is the active compound in Boerhavia diffusa? The primary bioactive compounds in Boerhavia diffusa include punarnavoside, rotenoids, and various alkaloids. These compounds are responsible for the herb's anti-inflammatory and immune-modulating properties demonstrated in research studies. ### How much inflammation reduction does Boerhavia diffusa provide? Animal studies show Boerhavia diffusa reduced paw edema by 55.78% in rat models. This significant anti-inflammatory effect suggests potential therapeutic benefits, though human studies are needed to confirm these results. ### Can Boerhavia diffusa boost immune function? Research indicates that alkaloidal fractions from Boerhavia diffusa enhanced antibody responses in mice while reducing hypersensitivity reactions. This suggests the herb may help balance immune system function rather than simply boosting it. ### Is Boerhavia diffusa safe with blood thinners? Boerhavia diffusa demonstrates antifibrinolytic activity, which could potentially interact with anticoagulant medications. Individuals taking blood thinners should consult their healthcare provider before using this herb to avoid potential interactions. ### What conditions is Boerhavia diffusa traditionally used for? In Ayurvedic medicine, Boerhavia diffusa (Punarnava) is traditionally used for kidney disorders, edema, and inflammatory conditions. Modern research supports some of these uses, particularly the anti-inflammatory and immune-modulating effects. ### Is Boerhavia diffusa safe during pregnancy and breastfeeding? Boerhavia diffusa has been traditionally used in Ayurvedic medicine, but there is insufficient clinical evidence to establish safety during pregnancy and breastfeeding. Its antifibrinolytic and prostaglandin-modulating properties suggest potential hormonal effects that warrant caution in these populations. Pregnant or nursing individuals should consult a healthcare provider before use. ### What is the most effective form of Boerhavia diffusa supplement? Boerhavia diffusa is available as dried root powder, standardized extracts, and whole plant preparations, with alkaloidal and aqueous extracts showing activity in research models. The bioavailability of active compounds may vary depending on extraction method and processing, though most clinical data derives from traditional decoctions and powdered forms. Standardized extracts may offer more consistent dosing, but direct head-to-head comparisons in human studies are lacking. ### How strong is the clinical evidence for Boerhavia diffusa's health benefits? Current evidence for Boerhavia diffusa is predominantly preliminary, based on animal studies (rats and mice) and traditional use rather than robust human clinical trials. While studies show promising results like 55.78% paw edema reduction in rodent inflammation models and immune-modulating effects, these findings cannot yet be reliably extrapolated to human efficacy. More rigorous human trials are needed to establish safety and effectiveness for specific health conditions. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*